UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 21, 2025

STANDEX INTERNATIONAL CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		1-7233		31-0596149
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification No.)

23 Keewaydin Drive, Salem, New Hampshire		03079
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (603) 893-9701

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, Par Value $1.50 Per Share	SXI	New York Stock Exchange

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company ☐

If an emerging growth company, indicates by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Standex International Corporation

SECTION 5 – CORPORATE GOVERNANCE AND MANAGEMENT

ITEM 5.07 a and b SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

The Company held its Annual Meeting of Stockholders on October 21, 2025. The number of common shares represented at the Annual Meeting of Stockholders was 11,304,234. The stockholders voted on the following proposals:

Proposal I – To elect two Directors to three-year terms ending on the date of the Annual Meeting of Stockholders in 2028:

Nominee	For	Against	Abstain	Non-Vote
For a three-year term
Thomas E. Chorman	9,623,949	1,253,659	1454	425,172
Andy L. Nemeth	10,859,557	17,250	2255	425,172

Proposal II – Advisory vote on the Company’s executive compensation:

For			10,660,832
Against			213,117
Abstain			5,113
Non-Vote			425,172

Proposal III – Ratification of appointment of Deloitte & Touche, LLP as Independent Public Accountants of the Company for the fiscal year ending June 30, 2026:

For			10,943,594
Against			359,021
Abstain			1619

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

STANDEX INTERNATIONAL CORPORATION

(Registrant)


	/s/ Ademir Sarcevic
	Ademir Sarcevic Chief Financial Officer

	Date: October 31, 2025

	Signing on behalf of the registrant and as principal financial officer

STANDEX INTERNATIONAL CORP/DE/ 8-K